CDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept Dr. Divya Colin3 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved Dr Reddys...
CDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan Dr. Divya Colin3 May 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has approved the protocol...
CDSCO Panel Approves Sanofi's Protocol Amendment to study Tolebrutinib Dr. Divya Colin20 April 2025 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Sanofi's proposal...
CDSCO Panel Approves Novartis Protocol Amendment Proposal fo Ianalumab study Dr. Divya Colin2 April 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Bristol Myers Squibb's Protocol Amendment Proposal to study Anti-cancer Drug Iberdomide Dr. Divya Colin21 March 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the Bristol Myers...
CDSCO Panel Approves Johnson and Johnson's Protocol Amendment proposal for Teclistamab study Dr. Divya Colin2 March 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Johnson and...
CDSCO Panel Approves Novo Nordisk Proposal Amendment Proposal for Etavopivat study Dr. Divya Colin9 Feb 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Approves Novo Nordisk Protocol Amendment Proposal for Concizumab study Dr. Divya Colin7 Feb 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Anti-cancer Drug Volrustomig study Dr. Divya Colin22 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Retatrutide study Dr. Divya Colin19 Jan 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Anti-cancer Drug LY3537982 Dr. Divya Colin10 Jan 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Novartis Protocol Amendment Proposal for Ruxolitinib study Dr. Divya Colin4 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
